1.
Sagacious Aldose Reductase Inhibition for Treatment of Metabolic Disorders. JOC [Internet]. 2025 Oct. 29 [cited 2025 Dec. 26];24(9s):410-8. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1503